drugset / Trial / NCT01774838

Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome

NCT01774838

Phase 3 Completed 49 enrolled University of Cologne
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To test the vasoactive and anti-inflammatory effects of prasugrel in patients with acute coronary syndrome endothelial function -as a surrogate parameter of NO bioavailability- and different markers of inflammation, oxidative stress and platelet activation will be assessed in patients with unstable angina.

Timeline

Start
2014-10
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg
Subject Prasugrel Small molecule 10 mg